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α-synuclein oligomers interact with ATP synthase
and open the permeability transition pore in
Parkinson’s disease
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Protein aggregation causes α-synuclein to switch from its physiological role to a pathological
toxic gain of function. Under physiological conditions, monomeric α-synuclein improves ATP
synthase efficiency. Here, we report that aggregation of monomers generates beta sheet-rich
oligomers that localise to the mitochondria in close proximity to several mitochondrial pro-
teins including ATP synthase. Oligomeric α-synuclein impairs complex I-dependent respira-
tion. Oligomers induce selective oxidation of the ATP synthase beta subunit and
mitochondrial lipid peroxidation. These oxidation events increase the probability of perme-
ability transition pore (PTP) opening, triggering mitochondrial swelling, and ultimately cell
death. Notably, inhibition of oligomer-induced oxidation prevents the pathological induction
of PTP. Inducible pluripotent stem cells (iPSC)-derived neurons bearing SNCA triplication,
generate α-synuclein aggregates that interact with the ATP synthase and induce PTP
opening, leading to neuronal death. This study shows how the transition of α-synuclein from
its monomeric to oligomeric structure alters its functional consequences in Parkinson’s
disease.
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Protein aggregation and mitochondrial dysfunction are twocentral pathogenic processes in both familial and sporadicParkinson’s disease (PD). However, the way in which these
two processes converge to cause neurodegeneration is unknown.
Missense mutations1,2, and duplications or triplications of the
SNCA gene, which encodes α-synuclein, lead to autosomal domi-
nant early-onset PD3,4, that is clinically and pathologically similar
to sporadic PD. Genetic and biochemical data suggest that, as the
concentration of α-synuclein increases, especially in the presence of
high levels of dopamine5, the tendency for it to self-aggregate and
form oligomers, and eventually fibrils also increases6. Aggregation
of α-synuclein from its monomeric to oligomeric form leads to
structural conformation changes in the protein that mediate the
toxic effects of α-synuclein within cells7–9.
We recently reported that α-synuclein, in its monomeric state,
interacts with, and regulates ATP synthase to improve the effi-
ciency of ATP production10. Here we investigate whether the
mitochondrial function of α-synuclein is structure-specific, and
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therefore adopted a range of methods including single-molecule
biophysical measurements, super-resolution microscopy, elec-
trophysiology, and dynamic fluorescent neuronal imaging to
describe the location and functional mechanism of oligomeric
species of α-synuclein, compared to monomeric species. We show
that α-synuclein oligomers come into close proximity with, and
exert, functional effects on several mitochondrial proteins. This
study focuses on its specific interaction with ATP synthase due to
the previously reported physiological interaction with α-synu-
clein, and the putative role of ATP synthase in the regulation and/
or composition of the PTP.
Results
Generation and characterisation of aggregated α-synuclein. We
generated aggregated forms of recombinant α-synuclein that were
characterised using a highly sensitive single-molecule method
termed Single Aggregate Visualisation by Enhancement (SAVE)
imaging, which uses single-molecule fluorescence microscopy to
detect the benzothiazole salt Thioflavin-T (ThT)11. Upon binding
to β-sheet structures, ThT fluorescence increases allowing indivi-
dual aggregated species to be detected (Fig. 1a). This can be fitted
to a two-dimensional Gaussian distribution to determine the
aggregate width along the longest axis (full-width half maximum),
in addition to the integrated intensity of each species (Fig. 1b).
From 2 h onwards, the number of diffraction limited fluorescent
puncta increases, which represents the emergence of oligomers. At
later time points (24 h), fibrils as long as 5 µm are observed. The
total integrated intensity also increases, representing the increased
crossed β-sheet content in the larger aggregates (Fig. 1b).
For this study, we utilised time points characteristically
represented by Fig. 1a (8 h), in which ~1% of the aggregation
mixture has formed β-sheet-rich oligomeric structures, and the
remaining 99% is monomeric. As a paired control to the oligomer
preparation, monomer sample from the starting time point of the
aggregation was used.
Oligomers induce mitochondrial dysfunction in whole cells. To
investigate the effect of structural conformation on mitochondrial
function, monomers and oligomers were applied to primary rat
co-cultures of neurons and astrocytes and the autofluorescence of
mitochondrial NADH (selected from NADH/NADPH auto-
fluorescence determined by activation and inhibition of NADH
consumption—see Fig. 1c) was assessed. 100 nM monomeric α-
synuclein induced a decrease in NADH autofluorescence in
wildtype (WT) neurons (Fig. 1c) suggesting consumption of
NADH through activation of respiration. In contrast, oligomers
(100 nM monomers, ~1 nM oligomers) induced a slow and pro-
gressive increase of NADH in mitochondria (Fig. 1c) confirming
inhibition of complex I by oligomeric α-synuclein (in agreement
with previous reports)12. However, more prolonged exposure of
cells with oligomers, in some neurons, induced a sudden drop in
mitochondrial NADH, which could be induced by rapid activation
of NADH consumption due to uncoupling of mitochondria or by
mitochondrial permeability transition pore (PTP) opening and
redistribution of NADH to cytosol (Fig. 1c). Inhibitor of mPTP
cyclosporin A (CsA) prevented this transient drop in mitochon-
drial NADH level (Fig. 1c). Impairment of complex I function
may affect the mitochondrial membrane potential (ΔΨm).
Application of oligomers (~1 nM oligomers) induced slow mito-
chondrial depolarisation, reflected in the slow increase in Rh123
intensity (Fig. 1d, e). This gradual depolarisation of the ΔΨm is in
accordance with oligomer-induced impairment of respiration and
reduced electron flow through the electron transport chain.
Monomers alone did not induce mitochondrial depolarisation,
and may even hyperpolarise mitochondria, as previously shown10.
Application of oligomers (~3 nM oligomers) also induced
sharp transient increases in Rh123 fluorescence intensity, which
appeared as discrete mitochondrial depolarisation events that
resembled PTP opening (Fig. 1f). When cells were pre-incubated
with the PTP inhibitor cyclosporine A, the oligomer-induced
PTP-like events were abolished (Fig. 1g).
PTP opening in mitochondria can be triggered by two major
stimuli, calcium and reactive oxygen species (ROS). First we
tested whether a physiological calcium stimulus, low concentra-
tion of glutamate (1 μM), could trigger PTP opening in the
presence of oligomers (~1 nM oligomers). Application of
glutamate to WT rat neurons leads to a rapid cytosolic calcium
influx with no significant alteration in the basal ΔΨm
(Supplementary Fig. 1). Incubation of WT rat neurons with
monomers for 6–9 min prior to the addition of glutamate-
induced a similar cytosolic calcium and ΔΨm response to control
(Fig. 1h). Conversely, exposure to oligomeric α-synuclein prior to
glutamate stimulation resulted in a glutamate-induced cytosolic
calcium response that was associated with rapid and transient
depolarisation with incomplete recovery to baseline, which
resembled PTP opening (Fig. 1h). Next, we assessed whether
oligomers altered the PTP threshold in response to laser-induced
ROS production. Cells loaded with fluo-4 and tetramethylrhoda-
mine methyl ester (TMRM) (ΔΨm; Fig. 1i), were treated with
oligomers and then exposed to high laser power. High laser power
generates ROS, which in turn triggers PTP opening that leads to a
rapid mitochondrial depolarisation reflected by a rapid fall in
TMRM signal (Fig. 1i). This is then followed by an increase in the
cytosolic fluo-4 fluorescence as the mitochondrial calcium
redistributes to the cytosol (note the appearance of TMRM drop
before fluo-4 increase; Fig. 1i). The threshold for PTP opening
was significantly lower in oligomer-treated cells when compared
to control conditions (HBSS only, p < 0.001; Fig. 1i) suggesting
that oligomers lower the threshold for ROS-induced PTP opening
in neuronal co-cultures.
Fig. 1 Characterisation of oligomers and their effect on mitochondria. a Representative SAVE images of early oligomers (4 h), late oligomers (8 h), and
fibrils (24 h). Zoom and representative two-dimensional Gaussian distribution fits are shown in the insets. The scale bar is 5 µm and 1 µm in the zoom, and
the colour bar shows the Gaussian amplitude (×104 photons). b Quantification of aggregation. Each detected species was fitted to a two-dimensional
Gaussian distribution, and histograms of the widths (FWHM) along the longest axis, and the total integrated intensities are shown for each time-point. c
Representative traces from single experiments, of NADH autofluorescence in WT neurons exposed to either monomers (n= 15 cells), oligomers (n= 32
cells), or oligomers ± CsA (n= 9 cells and n= 6 cells, respectively). d Representative Rh123 traces of cells challenged with oligomers. e Quantification of
mitochondrial depolarisation upon either monomeric or oligomeric application. N= 3 experiments; Oligomers: n≥ 60 neurons/astrocytes; Monomers: n≥
50 neurons/astrocytes. f Representative Rh123 traces of cells challenged with oligomers. g Representative Rh123 traces of cells challenged with oligomers
± CsA. h Representative traces of Rh123 and fura-2 in WT neurons exposed to glutamate in the presence of monomers or oligomers. i Representative
images of WT rat neurons labelled with fluo-4 (cytosolic calcium) and TMRM (ΔΨm) before (0 min) and after (4 min) high laser exposure which
represents PTP opening. A representative trace of TMRM and Fluo-4 fluorescence where the drop in TMRM fluorescence precedes increase in Fluo-4
fluorescence. Quantification of the time until PTP opening in WT cells pre-exposed to oligomeric α-synuclein. N= 3 experiments; n= 43 cells for control
and n= 20 cells for oligomers. Two-tailed Student’s t-test for e and i. Scatter points represent individual cells for e and i. Scale bar= 10 μm. Data
represented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001
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Oligomers induce PTP opening in isolated mitochondria. In
order to determine whether PTP opening was a direct effect of
oligomers within mitochondria, or a downstream effect of sec-
ondary cellular pathways, the effect of α-synuclein on isolated
mitochondria was investigated.
First, a swelling assay on isolated mitochondria was per-
formed13, in which mitochondrial swelling was estimated from
the kinetics of the intensity of the transmitted light. Monomers
(100 nM) or oligomers (100 nM monomer, ~1 nM oligomers)
were applied to energised mitochondria for 3–5 min, followed by
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stepwise additions of calcium applied to trigger PTP opening. In
the presence of monomers, PTP opening and mitochondrial
swelling were triggered after three additions of 25 μM calcium
(Fig. 2a), whereas oligomers triggered opening after the first
addition of 25 µM calcium.
Next, we employed mitochondrial electrophysiology to char-
acterise the alteration in membrane conductance that occurs
across the inner mitochondrial membrane in response to α-
synuclein. Mitoplasts were prepared from isolated mitochondria
and patch-clamp experiments were performed (Fig. 2b). Negative
control mitoplasts were prepared by passive swelling in substrate-
free and calcium-free media. Positive control mitoplasts were
prepared by swelling induced by calcium-treatment of energised
mitochondria to activate PTP. As expected, mitoplasts prepared
in the absence of calcium exhibited little or no ion channel
activity (Fig. 2c), while calcium-treated mitochondria demon-
strated high conductance channel activity (Fig. 2d, e), with
properties resembling the multiple conductance channel or PTP
characterised by an averaged peak conductance of ~3.6 nS.
Channel activity induced by α-synuclein was compared to
channel activity seen in calcium-treated mitoplasts.
When oligomers (~1–3 nM oligomers; 100–300 nM mono-
mers) were present in the pipette, all patches showed discrete ion
channel activity (average transition size of 0.46 ± 0.15 nS), not
seen in control (Fig. 2f for typical single channel behaviour and
Table 1). Furthermore, in 85% of these oligomer-treated patches
(Fig. 2i), channel activity was then followed, within 10 min, by the
opening of a megachannel (averaged peak conductance 1.9 ± 0.4
nS) (Fig. 2g and inset i–iv; Table 1) with the properties
resembling the PTP channel as seen in our control experiments
in the presence of calcium (Fig. 2d, e, h). Channel activity induced
by oligomers was inhibited by CsA and partially inhibited by
ADP further confirming its relationship to PTP (Fig. 2j–l).
Altogether, the detection frequency of PTP-like activity in the
presence of oligomers was comparable to the detection frequency
of Ca2+-induced PTP-like channel, and increased when com-
pared to channel activity seen in the absence of calcium (Fig. 2i).
Monomers (300 nM) induced small occasional channels, and
rarely induced a megachannel that exhibited a lower peak
conductance to the positive control calcium-induced PTP or
oligomer-induced PTP (Table 1). Oligomer-induced channel
activity and oligomer-induced PTP were not detected in the
presence of the antioxidant Trolox in the pipette.
Oligomers interact with the mitochondrial ATP synthase. We
previously demonstrated that monomeric α-synuclein interacts
with ATP synthase using co-immunoprecipitation and proximity
ligation assay (PLA). Here we investigated whether oligomeric α-
synuclein similarly interacts with ATP synthase. To distinguish
monomeric from oligomeric α-synuclein within cells, we utilised
a conformation-specific filament antibody, raised against aggre-
gated α-synuclein.
Due to the difficulty in preserving aggregate conformation with
biochemical methods, we adopted visualisation methods to study
at high precision the location and proximity of the α-synuclein
aggregate to the mitochondrial protein. The specificity of the
antibody for oligomers was tested by exposing WT rat co-cultures
to either 500 nM monomers or 500 nM oligomers (500 nM
monomers, ~5 nM oligomers) and performing immunocyto-
chemistry (Fig. 3a lower panel). In cells with exogenously added
oligomers, a signal could be detected 1 h following addition of
oligomers. After 1 day, and at 7 days, there was a significant
increase in the signal intensity and appearance of protein
aggregates within the oligomer-treated cells, reflecting the potent
ability of the oligomers to seed aggregation in the host cell14 and
for such aggregates to be detected by the antibody. Monomer-
treated cells did not show a significant signal using the filament
Ab (Fig. 3a upper panel).
Double immuno-labelling using the filament α-synuclein
antibody and an antibody raised against ATP synthase subunit
α in WT rat co-cultures exposed to oligomers (Fig. 3b)
demonstrated areas of co-localisation of aggregated α-synuclein
and the ATP synthase. To overcome the diffraction limit of
conventional confocal microscopy, super-resolution microscopy
was employed11,15. DNA-PAINT utilises fluorophore labelled
DNA imaging strands that transiently bind to their complemen-
tary docking strands that are conjugated to secondary antibodies
(see schematic diagram, Fig. 3c). We used two different docking
strand sequences with their complementary imaging strand pairs
labelled with either ATTO655 or CY3B to simultaneously image
α-synuclein aggregates and ATP synthase, respectively. Due to the
high photon numbers from these fluorophores, we achieved a
Fig. 2 Oligomers but not monomers induce PTP opening. a Mitochondrial swelling was measured by changes in optical density (D) in the presence of buffer,
monomers, and oligomers. Complete mitochondrial swelling was achieved by the addition of 5 μM alamethicin. b Schematic diagram of mitoplast preparation
and patch-clamp experiment. c Patch clamp recording of the inner membrane from control mitoplasts prepared in calcium-free media in the absence of
mitochondrial energy substrates. d Patch clamp recording of the inner membrane from control mitoplasts prepared in calcium media in the presence of
succinate showing activation of PTP. e Typical multi-conductance state of single PTP channel, induced by calcium (positive control). f Novel channel activity
detected in the presence of α-synuclein oligomers in the pipette solution, other conditions the same as in a. g Oligomer-induced gradual development of
channel activity (i and ii), which later transformed into full conductance channel resembling PTP (iii) which was inactivated/closed by the application of high
negative potential (iv). h Current amplitude histogram of the channel shown in e. i Detection frequency of the PTP channel in different experimental conditions.
j Effects of PTP inhibitors CSA (1 µM) and ADP (1mM) on channel activity. k, l Current amplitude histogram of the channel shown in j
Table 1 Alpha-synuclein-induced channel activity and PTP opening in mitochondrial inner membrane patches
[−] Control [+] Control Monomers Oligomers Oligomers+ Trolox (in the pipette)
IMM basal membrane conductance [nS] 1.26±0.28 0.24±0.02 0.29±0.12 1.6±0.5 0.52±0.2
Channel occurrence, % of total recordings 27 50 50 100 0
Channel predominant transition size [nS] 0.31±0.16 0.75±0.53 0.46±0.26 0.46±0.15 N/A
PTP occurrence, % of total recordings 10 100 25 85 0
PTP peak conductance [nS] 2.5±1.5 3.1±0.8 1.3±1.3 1.9±0.4 N/A
Time until onset of PTP development [min] 3 1–3 5 9 N/A
IMM: inner mitochondrial membrane; PTP: permeability transition pore
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precision of 28 nm and 29 nm for ATP synthase and α-synuclein,
and because each antibody could be localised multiple times using
the PAINT methodology, we measured more than 500,000
localisations in each channel, achieving a resolution of 45–108 nm
and 46 nm for α-synuclein and ATP synthase, respectively. At
this resolution, there were clear areas within the cell in which
aggregates of α-synuclein are co-localised with the ATP synthase
(Fig. 3c). To further quantify this, we determined the association
quotient, Q, for the ATP synthase and α-synuclein filament
localisations, which is a measure of the coincidence between the
images (see Methods). This was determined to be 0.48. Similar
experiments were performed with antibodies to an outer
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mitochondrial protein, TOMM20, and an inner mitochondrial
membrane protein, Complex 1 (resolution= 154 nm and 58 nm,
respectively). Regions of co-localisation were also observed
between α-synuclein and inner and outer membrane proteins
(co-incidence coefficients of 0.31 for TOMM20; 0.62 for Complex
1) reflecting the reported potential interactions of α-synuclein
with complex 1 and TOMM20 in the literature (Supplementary
Fig. 2).
To further explore a potential interaction between aggregated α-
synuclein and ATP synthase, in situ proximity ligation assay (PLA;
Fig. 3d) was utilised. 500 nM monomers, oligomers (500 nM
monomers, ~5 nM oligomers), or buffer were applied to rat co-
cultures and a PLA signal between the antibodies against filament
α-synuclein and ATP synthase subunit α was observed, confirm-
ing an interaction between aggregated α-synuclein and ATP
synthase. Microtubule-associated protein 2 (MAP2) staining was
used to identify neuronal cells. Oligomer-treated cells showed a
significantly increased interaction between the oligomers and ATP
synthase compared to the equivalent concentration of monomers
only or control preparation (p < 0.01; Fig. 3e). The mitochondrial
protein, TOMM20, was probed for to validate the mitochondrial
localisation of the PLA signal (Fig. 3f). Further, a PLA was carried
out to probe for complex I and filament α-synuclein to act as a
positive control for an interaction of α-synuclein with another
mitochondrial protein (Supplementary Fig. 3A). As a negative
control a PLA between the nuclear histone H3 and filament α-
synuclein was used (Supplementary Fig. 3B, C).
Oligomers induce non-enzymatic ROS production. Oligomers
are potent inducers of cellular ROS7, and we hypothesised that this
contributes to the oligomer-specific effects. To test whether aggre-
gates of α-synuclein are intrinsically redox-active, we employed a
cell-free method of testing oxidation which relies on dihy-
droethidium (DHE) oxidation after application of α-synuclein16.
Xanthine/xanthine oxidase ROS production was used as a positive
control (Fig. 4a, b). Application of 300 nM monomers (Fig. 4a, b)
did not induce any significant oxidation of DHE. However, appli-
cation of oligomers (300 nM monomers, ~3 nM oligomers) induced
oxidation of DHE in the absence of cells (Fig. 4a, b).
Previously we have shown that oligomers could induce lipid
peroxidation17. Oligomers may be able to induce targeted
oxidation at the site of their action, that is, in the vicinity of
ATP synthase at the inner mitochondrial membrane. Membrane
lipid peroxidation was tested using C11-BODIPY 581/591, (Fig.
4c). An increase in lipid peroxidation following application of
oligomers (500 nM monomers, ~5 nM oligomers) in intact
neurons and astrocytes was observed, in agreement with previous
findings15 (Fig. 4d, e, i). Next, C11-BODIPY 581/591-loaded cells
were permeabilized using digitonin to isolate the mitochondria,
allowing an assessment of mitochondrial lipid peroxidation
(Fig. 4c). Application of oligomers to permeabilized cells induced
lipid peroxidation in mitochondrial membranes of neurons,
astrocytes, and mixed processes (Fig. 4f–i).
Taken together, oligomers generate ROS as an intrinsic
property of the oligomer, and are able to oxidise lipid membranes
at their site of action, in particular at the inner mitochondrial
membrane.
Oligomeric α-synuclein oxidises ATP synthase subunits.
Excessive production of ROS can damage lipid, proteins, and
other molecules. The formation of extremely harmful ROS can
mediate direct oxidation of proteins18,19. In particular, hydroxyl
radical readily oxidises sulphur-containing amino acids like
methionine and cysteine, thus altering protein conformation and
function. Using redox proteomics, we investigated oxidative
posttranslational modifications (PTMs) of the ATP synthase in
mitochondrial fractions treated with either monomers or oligo-
mers. The obtained data revealed significant oligomer-dependent
oxidative modifications of ATP synthase subunit β but not the
ATP synthase subunit α, and selected other mitochondrial pro-
teins shown for comparison. (Table 2). Treatment with 100–500
nM α-synuclein (~1–5 nM oligomer) led to a 6–8-fold increase in
the number of oxidised amino acids compared to control
(untreated) samples, while treatment with 100–500 nM monomer
only led to a 3–4-fold increase in oxidised amino acids compared
to untreated (Table 2; Supplementary Table 1). To quantify these
effects, we immunoprecipitated the ATP synthase from the iso-
lated mitochondria fractions, and then analysed the ratio of
peptides with oxidised methionine vs non-oxidised ([Met(O)]/
[Met]) peptides. This analysis revealed a highly significant
increase of some Met(O) peptides compared to Met peptides of
ATP synthase subunit β on oligomer treatment. A representative
data of the ratio of four such peptides, one strongly affected by
treatment with oligomers (SLQDIIAILGMDELSEEDKLTVSR),
and the others not significantly altered is shown in Supplemen-
tary Fig. 6.
One of the most common modifications was found to be
oxidised methionine. Beside cysteine, methionine is another
sulphur-containing AA implicated in the antioxidant protection
of proteins in order to preserve their structure and function20,21.
Although oxidation of methionine can be reversed, this PTM may
act as a regulatory switch, and can inhibit the phosphorylation of
adjacent amino acids sites, such as serine, threonine, or tyrosine,
thereby altering protein function. However, the function of
oxidation of the sites in ATP synthase highlighted with this data,
is not yet known.
Oligomer-induced toxicity is dependent on PTP opening. To
investigate whether oligomer-induced PTP opening was respon-
sible for oligomer-induced toxicity, monomeric (500 nM) or oli-
gomeric α-synuclein was applied to cells overnight and cell death
was quantified by assessing the ratio of propidium iodide (PI) and
Hoechst positive cells. Oligomers (500 nM monomer, ~5 nM
Fig. 3 Oligomers co-localise with ATP synthase. a Representative images of rat neuronal co-cultures treated with either monomers or oligomers over
7 days and probed with a filament specific antibody. The nucleus can be seen in blue (DAPI). b Representative immunocytochemistry images of rat
neuronal co-cultures treated with oligomers. The cells were probed for ATP synthase subunit-α and filament α-synuclein. The nucleus can be seen in blue
(DAPI). Scale bar= 10 μm. c Left: diffraction limited image of α-synuclein (scale bar= 5 µm). Right: super-resolved images of α-synuclein and ATP
synthase and merged imaged (scale bars are 500 nm). Schematic diagram of DNA-PAINT: The secondary antibody conjugated with a docking strand binds
the primary antibody. A fluorophore labelled complementary imaging DNA strand binds the docking strand on the secondary antibody allowing super-
resolution imaging. d Representative PLA images of cells treated with either monomers, oligomers or no synuclein probing for ATP synthase subunit α and
filament α-synuclein. Cultures were counterstained with the neuronal marker, MAP2. Scale bar= 10 μm. e Quantification of PLA signals per cell. N= 3
experiments. Oligomers: n= 182 cells; Monomers: n= 117; Control: n= 134 cells. f Representative PLA images of cells treated with oligomers probing for
ATP synthase subunit α and filament α-synuclein. TOMM20 was probed to validate the mitochondrial localisation of the PLA signal. Two-tailed Student’s t-
test for e. Scatter points represent number of puncta per cell. Data represented as mean ± SEM. ***p < 0.001
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oligomers) alone induced a significant increase in cell death
compared to buffer control (p < 0.001; Fig. 4j, k). Co-incubation
with a PTP inhibitor (CsA) was able to reduce this cell death
significantly (p < 0.05). Interestingly, co-incubation with a
mitochondrial-located antioxidant (MitoQ) was also effective in
preventing oligomers induced cell death.
SNCA triplication iPSCs exhibit early PTP opening. In familial
PD, there is a correlation between the number of SNCA alleles
and severity of pathology22. To recapitulate the SNCA gene
dosage effect in human systems, we utilised two models: (1)
transgenic Shef4 human embryonic stem (hES) cells engineered
to overexpress (OE) two different levels of SNCA, on an isogenic
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background (Supplementary Fig. 4A), and (2) inducible plur-
ipotent stem cells (iPSCs) from a PD patient with a triplication in
the SNCA locus, a control unaffected first-degree relative23 and an
isogenic control (Supplementary Fig. 5A, B). iPSC-derived cor-
tical neurons from three disease, three control independent
clones, and one isogenic control clone were generated using
standard protocols, and experiments were performed on a
minimum of three independent inductions. These protocols
generated cultures that were 90% neuronal (as demonstrated by
Tuj1 positive staining), and 70% of the neurons demonstrated
glutamate-induced calcium responses (Supplementary Fig. 5A, B).
Immunocytochemistry using the conformation-specific fila-
ment α-synuclein antibody demonstrated a higher signal in the
triplication neurons (Fig. 5a), suggesting higher levels of
endogenous aggregated α-synuclein in triplication neurons
compared to control and isogenic control. PLA showed a
significant increase in the number of fluorescent puncta in the
SNCA triplication neurons showing that endogenous aggregated
α-synuclein in the iPSC-derived neuronal model interacts with
the ATP synthase (p < 0.001; Fig. 5b). Puncta could also be
observed in control iPSC neurons potentially reflecting the
existence of low levels of physiological conformers of α-synuclein
in control neurons. The mitochondrial protein, TOMM20, was
used to validate the mitochondrial localisation of the PLA signal.
Δψm was assessed in hES and iPSC-derived neurons using
TMRM. At days 70–90 post-differentiation, triplication neurons
demonstrated reduced ΔΨm compared to control and isogenic
control cells (Fig. 5c, d; hESC α-syn OE, Supplementary Fig. 4B).
Further, depolarisation upon application of oligomycin (complex
V inhibitor) revealed that the ΔΨm in triplication neurons is
maintained by the ATP synthase working in the reverse mode
(ATPase; Fig. 5e; hESC α-syn OE, Supplementary Fig. 4C).
Interestingly, the NADH redox index, which was assessed in % by
maximal activation of NADH mitochondrial consumption by
FCCP (0%), and maximal inhibition of NADH consumption by
mitochondrial ETC inhibitor, sodium cyanide (100%) in triplica-
tion neurons was significantly higher compared to control (p
<0 .01; Fig. 5f, g) suggesting that the resting level of NADH was
elevated due to impaired consumption of NADH by complex I
(hESC α-syn OE; Supplementary Fig. 4D, E). Importantly,
isogenic control cells had a comparable NADH redox index to
control neurons (Supplementary Fig. 5C).
The mitochondrial calcium capacity determines the threshold
at which PTP opening occurs. Whole neurons were loaded with
TMRM (Fig. 6a) and challenged with increasing concentrations of
the calcium ionophore ferutinin in a stepwise fashion (Fig. 6b).
The electrogenic calcium ionophore ferutinin is able to induce a
rise in mitochondrial calcium24–26, and here the concentration of
ferutinin required to induce PTP opening (confirmed by the rapid
loss of TMRM signal; Fig. 6b) was determined. PTP opening
occurred at significantly lower concentrations of ferutinin in
triplication neurons when compared to control (p < 0.001; Fig.
6c). Thus, the lower calcium-induced PTP opening threshold in
the triplication neurons suggests that the aggregated forms of α-
synuclein within the cell lead to premature PTP opening. The
PTP opening threshold in triplication neurons was further tested
in response to laser-induced ROS. Administering a high laser
power induced earlier PTP opening in triplication lines compared
to control cells which could be delayed by preincubation of the
neurons with CsA (p < 0.001; Fig. 6d, e; hESC α-syn OE,
Supplementary Fig. 4F-H).
Vulnerability to cell death of the triplication neurons was
assessed in the presence or absence of oligomers (Fig. 6f). Basal
cell death was increased in triplication neurons compared to
control and isogenic control neurons (Fig. 6g). Incubation with
500 nM oligomeric (~5 nM oligomers) α-synuclein significantly
increased the basal death in controls (p < 0.05; Fig. 6g). Co-
application of the PTP inhibitor CsA prevented the oligomer-
induced toxicity and restored cell death levels back to basal.
In human SNCA triplication and ES α-synuclein OE neurons,
high levels of endogenously aggregated α-synuclein lead to lower
ΔΨm, impaired mitochondrial respiration and a lower threshold
for PTP opening.
Discussion
Studies in cell lines and transgenic mice have previously observed
mitochondrial pathology associated with synucleinopathy27–32.
However, the nature of the toxic α-synuclein aggregate, and the
mechanism by which it induces mitochondrial pathology remains
unresolved. Applying single-molecule methods (to select aggre-
gates by their structure and size) to isolated mitochondria, pri-
mary rodent neurons, and human iPSC-derived neurons
permitted a tractable mechanism of α-synuclein induced toxicity
to be resolved. Our study identifies that α-synuclein oligomers
induce mitochondrial dysfunction, ultimately leading to neuronal
death by activating the mitochondrial PTP. The mitochondrial
PTP may therefore represent a convergence between protein
aggregation and neuronal mitochondrial dysfunction in PD.
Super-resolution microscopy, and proximity ligation assays,
confirmed that α-synuclein aggregates can localise to the mito-
chondrial membrane of rodent and human neurons, where they
come into close proximity with a number of key mitochondrial
proteins. In accordance with previous reports12, we show that α-
synuclein oligomers interact with, and impair complex 1
respiration, leading to slow depolarisation of the mitochondrial
membrane potential. Of major importance in this study, we
demonstrated that the soluble, β sheet-rich oligomers of α-
synuclein directly induce PTP opening. PTP opening is an event
in which an increase in permeability of the inner mitochondrial
membrane occurs due to opening of a high conductance
megachannel in the inner mitochondrial membrane called the
PTP, leading to equilibration of ionic gradients and solutes,
swelling of the matrix, cristae unfolding, rupture of the outer
mitochondrial membrane and ultimately cell death33–35. We
deployed a range of methods, including (1) fluorescent imaging of
rapid mitochondrial depolarisation in whole cell preparations, (2)
Fig. 4 Oligomeric α-synuclein generates ROS and induces lipid peroxidation. a Representative trace of ROS generation by xanthine oxidase/xanthine (N= 3
experiments; n= 14 regions), monomers (N= 3 experiments; n= 10 regions), and oligomers (N= 6 experiments; n= 24 regions) in a cell-free system. b
Quantitative analysis of the cell-free DHE oxidation. c Representative images of C11-BODIPY 581/591 labelled cells and areas analysed: (n) neurons, (a)
astrocytes, and (p) processes before and after permeabilization with 30 µM Digitonin. d Averaged traces of oligomer-induced lipid peroxidation of neurons
and e astrocytes before permeabilization. f Averaged traces of lipid peroxidation after permeabilisation of mitochondria in neurons (f), astrocytes (g), and
mixed processes (h). i Quantitative analysis of the data of neurons (N= 3 experiments; n= 26 cells), astrocytes (N= 3 experiments; n= 16 cells),
neuronal mitochondria (N= 3 experiments; n= 21 regions), astrocytic mitochondria (N= 3 experiments; n= 20 regions), and mixed processes
mitochondria (N= 3 experiments; n= 28 regions). j Representative images and k cell death quantification of cells treated with either control buffer,
oligomers (n= 264 cells), oligomers+ CsA (n= 189 cells), or oligomers+MitoQ (n= 258 cells). N= 3 experiments. Two-tailed Student’s t-test (b, i).
One-way ANOVA with Bonferroni correction (f) and scatter points represent sampled fields of view (k). Data represented as mean ± SEM. Scale bar=
10μm. *p < 0.05; **p < 0.01; ***p < 0.001
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mechanical swelling assay of isolated mitochondria, and (3)
electrophysiological detection of a megachannel in mitoplasts,
which together confirmed that oligomeric but not monomeric α-
synuclein, can induce PTP. The molecular identity of PTP
remains controversial. In early studies, proposed candidates have
included ANT, VDAC, phosphate carrier PiC, and misfolded
proteins36–40. More recent evidence suggests that the ATP syn-
thase components can be critically involved in the formation of
PTP channel either through reorganisation of C-subunit ring or
through dimerisation of ATP synthase complex, although an
essential role of ATP synthase in PTP formation has been ques-
tioned41–47. In this study, we do not attempt to define the com-
position of the PTP, especially in light of the debate in the
literature regarding this. However, our data suggests that the
probability of PTP opening may be regulated by an interaction
between monomeric and oligomeric α-synuclein with ATP syn-
thase, and that oligomer-induced oxidation events increase
the probability of PTP opening in disease. Understanding why
the ‘pathological’ oligomer specifically opens the PTP, while the
‘physiological’ monomer is unable to do so, is fundamental to
understanding how aggregation induces mitochondrial toxicity.
One major difference between monomer and oligomer lies in
the enriched β-sheet, hydrophobic structure that enables the
oligomer to interact with the inner mitochondrial membrane and
form channels, which we have demonstrated occurs in isolated
mitochondria preparations. The second major difference is the
unique intrinsic property for oligomeric structures to generate
ROS independently of cellular enzymatic systems, a property that
has been recognised for other aggregates of amyloidogenic pro-
teins48. Interestingly we have previously shown that, in its
unfolded state, the monomeric form of α-synuclein interacts with
ATP synthase. Here we utilise a conformation-specific antibody
combined with PLA and super-resolution microscopy to
demonstrate that, in the oligomeric state, α-synuclein still comes
into close proximity with ATP synthase. Whilst both mono-
mers10 and oligomers can interact with the ATP-synthase, they
exert different effects on the ATP synthase function: monomers
improve the efficiency of ATP synthesis10. In contrast, one major
consequence of oligomers when applied to isolated mitochondria
is to induce oxidative modifications, specifically to the ATP
synthase β subunit, demonstrated by redox proteomics. The ATP
synthase is known to be susceptible to oxidative/nitrosative
stress49. PTMs of specific residues of ATP synthase induced by
ROS can affect both the catalytic activities of ATP synthase and
potentially induce its PTP-forming activity31. Redox-active
oligomeric complexes are therefore able to oxidise their target
proteins in the inner mitochondrial membrane, and additionally
induce lipid peroxidation of the mitochondrial membrane.
Notably, free radical scavenger/antioxidant in isolated mito-
chondrial preparations (using Trolox) and whole cells (MitoQ),
prevents the oligomer-induced PTP opening, presumably through
preventing oligomer-induced oxidation events. This supports the
conclusion that the oligomer induces the PTP via inducing oxi-
dation of target proteins and mitochondrial lipids, while the
monomer is unable to so.
This mechanism may be relevant in the human brain during
the course of PD. SNCA mutations, and in particular the SNCA
triplication, lead to an early onset autosomal dominant form of
PD with dementia, associated with widespread α-synuclein
aggregation throughout the cortex and midbrain. Moreover,
there is a correlation between the SNCA gene dosage (and α-
synuclein expression level) and disease severity. We utilised
human neurons expressing different levels of endogenous α-
synuclein on an isogenic background, and control and iPSC-
derived neurons bearing a SNCA triplication, to model the effect
of increased expression and aggregation of α-synuclein in disease.
Elevated endogenous expression of α-synuclein induces mito-
chondrial dysfunction, characterised by impaired respiration and
mitochondrial membrane depolarisation. Notably endogenous α-
synuclein aggregates in these models also interact with mito-
chondrial proteins, impair respiration, and induce early PTP
opening and neuronal death. The neuronal death in these models
can be prevented by the use of PTP inhibitors, or by preventing
oligomer-induced oxidation events within the mitochondria.
Our data proposes the hypothesis that monomeric form of α-
synuclein, under normal conditions, interacts with and enhances
the efficiency of ATP synthase. During disease, aggregation of
monomeric α-synuclein is triggered, and this generates a series of
intermediate oligomers with increasing enrichment of β sheet
structures. These structures are in close proximity to inner
mitochondrial membrane proteins, and act to inhibit complex 1
function, and generate targeted oxidation events on interacting
proteins, and lipids. Aggregates of α-synuclein generate a pool of
bioenergetically compromised mitochondria under oxidative
stress. Oligomer-induced oxidation events ultimately lead to
opening of a megachannel, the mitochondrial permeability
transition event (Fig. 7). Additionally, oligomers sensitise cells to
known PTP triggers as they induce increased levels of ROS
production and calcium dysregulation, lowering the threshold for
PTP opening in response to other stimuli8,9,50. Aging is a major
Table 2 Oxidation of amino acids by treatment with α-synuclein
Accession Description Gene ΣCoverage Σ# Unique Peptides Σ# Modified AA #
AAs
MW
[kDa]
C 100
M
100
O
500
M
500
O
C 100
M
100
O
500
M
500
O
C 100
M
100
O
500
M
500
O
G3V6D3 ATP synthase
subunit beta
Atp5b 58.22 61.81 50.47 55.95 58.22 19 20 16 18 19 1 3 6 4 8 529 56.3
F1LP05/
P15999
ATP synthase
subunit alpha
Atp5a1 36.89 41.95 39.78 37.79 39.42 14 14 14 12 13 2 3 0 2 3 553 59.8
P04636 Malate
dehydrogenase,
mitochondrial
Mdh2 44.97 39.64 38.17 32.25 38.46 11 10 9 7 9 2 2 2 2 1 338 35.7
Q66HF1 NADH-
ubiquinone
oxidoreductase
75 kDa subunit,
mitochondrial
Ndufs1 33.98 29.16 32.74 31.91 20.77 17 15 15 15 9 1 0 0 1 0 727 79.4
P10860 Glutamate
dehydrogenase
1, mitochondrial
Glud1 25.27 31.18 32.44 23.12 27.96 10 11 11 8 10 0 0 1 1 0 558 61.4
C: untreated control; M: monomers; O: oligomers; 100: 100 nM; 500: 500 nM
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factor in PD, and although difficult to recapitulate in vitro, it is
likely that age-related decline in bioenergetics, redox homeostasis,
and mitochondrial calcium capacity, contribute to the aggregate
induced pathology to accelerate pathogenesis. Mitochondrial PTP
opening may therefore be a common pathway by which oligo-
meric α-synuclein induces cell death in human neurons. This
work resolves how a change in the structure of a protein transi-
tioning to its oligomeric state, alters its functional consequence.
Such insights are fundamental to understanding how the process
of protein aggregation generates toxic oligomeric species that may
be directly pathogenic in neurodegenerative diseases.
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Fig. 5 Impaired mitochondrial function in SNCA triplication iPS derived neurons. a Representative ICC images of control, isogenic control, and triplication
cells probed for filament α-synuclein. The nucleus can be seen in blue (DAPI). b Representative PLA images and quantification of control and triplication iPS
derived neurons showing a close proximity between filament α-synuclein and ATP synthase with the nucleus in blue (DAPI). TOMM20 was probed for to
validate the mitochondrial localisation of the PLA signal. N= 3 experiments; control n= 155 cells, and triplication n= 115 cells. c Representative images of
control and triplication iPS derived neurons loaded with TMRM and d ΔΨm quantification. N= 3 experiments, n≥ 32 cells. e Representative traces of TMRM
fluorescence in control and SNCA triplication neurons after addition of oligomycin (2 μg/ml), rotenone (1 μM), and FCCP (1 μM). f Representative trace of
NADH in control and triplication iPS derived neurons. FCCP is applied to maximise respiration and therefore minimise the NADH pool and NaCN is added to
block the mitochondrial respiration and therefore maximise the NADH pool. g Quantification of the redox index in control (N= 3 experiments, n= 112 cells)
and triplication iPS derived neurons (N= 3 experiments, n= 148 cells). Two-tailed Student’s t-test for b, d, g. b Scatter points on scatter column represent
number of puncta per cell. d, g Scatter points represent individual cells/areas. Data represented as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001
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Methods
Animals. Sprague–Dawley rat pups 1–3 days postpartum (University College
London breeding colony) of either sex were used for neuronal co-cultures and
experimental procedures were performed in full compliance with the United
Kingdom Animal (Scientific Procedures) Act of 1986.
WT rat neuronal co-cultures. Cultures of midbrain neurons and glial cells were
prepared from postnatal Sprague–Dawley pups (day 1–3; UCL breeding colony).
Midbrains were placed in ice-cold HBSS (Ca2+, Mg2+-free; Invitrogen). The tissue
was minced, trypsinized (0.1% for 10 min at 37 °C), triturated and plated on poly-
D-lysine-coated coverslips. The cells were cultured in Neurobasal medium (Invi-
trogen) supplemented with B-27 (Invitrogen), 2 mM L-Glutamine and penicillin
(50 I.U./ml)/streptomycin (50 μg/ml). The cultures were maintained at 37 °C (5%
CO2) and the media changed twice a week. Cells were used at 12–15 days in vitro.
Neurons were easily distinguishable from glia as they appeared brighter with
smooth rounded somata with distinct processes. Neurons lay just above the focal
plane of the glial layer.
iPSC-derived neurons. iPSC control lines SFC840-03-01, SFC840-03-03, and
SNCA triplication lines SFC831-03-01, SFC831-03-03, and SFC831-03-05 were
derived and characterised at the University of Oxford, James Martin Stem Cell
Facility, and control iPSC line SBAD04-01 was derived and characterised at the
University of Newcastle from Lonza fibroblasts CC-2511, Lot 264781, by the
StemBANCC consortium51,52. iPSC lines AST3 and AST8 were derived from a
patient with a SNCA triplication, NAS6 and NAS7 were derived from an unaffected
first-degree relative23. iPSCs were cultured on matrigel in Essential 8 medium
(ThermoFisher) and passaged using collagenase. Differentiation of cells into neu-
rons was induced by dual SMAD inhibition using SB431542 (10 μM, Abcam) and
LDN (100 nM Abcam) in knockout DMEM (ThermoFisher), followed by
maturation in N2B27 medium (ThermoFisher) supplemented with BDNF and
GDNF (20 ng/ml and 10 ng/ml, Peprotech)53. Cells were passaged using accutase
after 11 days, and seeded onto plates coated with poly-l-ornithine, laminin and
fibronectin (Sigma). Cells were passaged approximately three more times before
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being used at days 70–90 after the start of differentiation. iPSC-derived cortical
neurons from three patients (SNCA ×3) clones and three control clones were
generated using standard protocols, and all experiments were performed on a
minimum of three independent inductions. Experiments were repeated using the
SNCA ×3 clones, and an isogenic clone generated from the same patient. Briefly,
the isogenic cell line was generated from a SNCA ×3 iPSC clone by CRISPR/Cas9
double nickase gene editing to knockout 2 SNCA alleles, reducing the allele dosage
from four (in the triplication cells) to two (normal), as confirmed by DNA
sequencing. This method retains the rest of the triplication locus intact, and
therefore provides the ideal control for the effects of SNCA triplication alone.
hES-derived neurons. The hESC line was kindly provided by Dr. David Hay
(University of Edinburgh), upon MRC Steering Committee approval (ref. no.
SCSC11-60). The line was established at the Centre for Stem Cell Biology (Uni-
versity of Sheffield) under a license from the Human Fertilisation and Embryology
Authority, and has been validated to show the standard hESC characteristics
including a normal karyotype33. Neural induction by dissociation of hES cells into
single cells with Accutase (Gibco, Cat. no. A11105-01) and plated on a Matrigel-
coated 6-well plate in mTeSR1 medium. Cells were fed daily until they reached 90%
confluency or above. Neural induction started at day 0, when mTeSR1 was replaced
with hESC medium lacking FGF2, supplemented with 10 μM SB431542 (Tocris)
and 100 nM LDN-193189 (Stemgent). Cells were fed daily with this medium until
day 4. From day 5 to day 11, SB431542 was withdrawn and cells were fed every
other day with a mixture of hESC medium and N2B27, which was gradually added
into culture medium from 25%, 50%, 75%, and 100% at day 5, day 7, day 9, and day
11, respectively53. To generate cortical neurons, human pluripotent stem cells were
processed based on a protocol described above for the iPSC-derived neurons54.
pCAG-SNCA-IRES-Venus or the control pCAG-IV were transfected into hES cells
followed by antibiotic selection to allow the generation of clones with stable
expression of SNCA. Clones exhibiting normal morphology, growth and differ-
entiation behaviour were selected and characterised for SNCA expression, and two
clones with near normal levels of SNCA expression (here designated control) and
high levels of SNCA expression (designated as hES OE syn) were utilised for
further studies.
Aggregation of α-synuclein. For the aggregation reactions, a 70 μM solution of
wild-type α-synuclein in 25 mM Tris buffer with 100 mM NaCl (pH 7.4; 0.01%
NaN3 was added to prevent bacterial growth during aggregation) was incubated at
37 °C with constant agitation at 200 rpm (New Brunswick Scientific Innova 43),
during which time aliquots were taken. All aggregations were conducted in LoBind
microcentrifuge tubes (Eppendorf) to limit surface adsorption.
Preparation of ThT solution. ThT stock solutions were prepared by diluting ThT
(Sigma-Aldrich, T3516) into neat ethanol (Sigma-Aldrich, 459836) to give a final
concentration of ∼1M. Following this, a dilution into PBS was performed to give a
∼50 μM stock solution of ThT. The ThT solution was freshly filtered each day
(0.02 μm syringe filter, Whatman, 6809–2101), and the exact concentration was
determined from the absorbance at 412 nm using an extinction coefficient of 36
000M−1 cm−1. The stock solution was stored in the dark at 4 °C, and was only
used for a maximum of 2 weeks after preparation.
Preparation of slides for SAVE imaging. Borosilicate glass coverslips (20 × 20
mm, VWR, 631-0122) were cleaned using an argon plasma cleaner (PDC-002,
Harrick Plasma) for at least 1 h. Frame-seal slide chambers (9 × 9 mm2, Biorad,
Hercules, CA, SLF-0601) were attached to the glass, and 50 μL of poly-L-lysine (70
000–150 000 molecular weight, Sigma-Aldrich, P4707) was added to the well and
incubated for at least 30 min, before being washed with PBS buffer. Prior to
imaging, the coverslides were first checked for fluorescent impurities in 5 μM ThT.
SAVE imaging. Imaging was performed using a homebuilt total internal reflection
fluorescence microscope11. This imaging mode restricts detectable fluorescence
signal to within 200 nm from the sample slide. For imaging of WT α-synuclein in
the presence of 5 μM ThT, the output from laser operating at 405 nm (Oxxius
LaserBoxx, LBX-405-100-CIR-PP) was aligned and directed parallel to the optical
axis at the edge of a 1.49 NA TIRF objective (APON60XO TIRF, Olympus,
N2709400), mounted on an inverted Nikon Eclipse TiE microscope. Fluorescence
was collected by the same objective and was separated from the returning TIR
beam by a dichroic (Di01-R405/488/561/635, Semrock), and passed through an
emission filter (BLP01-488R). The images were recorded on an EMCCD camera
(Evolve 512, Photometrics) operating in frame transfer mode (EMGain of 11.5 e–/
ADU and 250 ADU/photon). Each pixel was 160 nm in length. For each data set,
3 × 3 image grids were measured in three different regions of the cover slide. The
distance between the nine images measured in each grid was set to 350 μm, and was
automated (bean-shell script, micromanager) to prevent user bias. Images were
recorded at 50 frames s−1 for 100 frames with 405 nm illumination (150–200W/
c2).
Data analysis of SAVE images. Data analysis was performed using a custom-
written script in Igor Pro (Wavemetrics). For each image, the stacks were first
averaged over 100 frames, and the background subtracted. Fluorescent species were
detected by applying a threshold of five standard deviations above the mean image
intensity, and were subsequently fit to two-dimensional elliptic Gaussian dis-
tributions. The integrated intensities of the fits and the maximum widths were
determined and presented in histograms (Fig. 1b).
Single channel patch-clamp recordings. Single channel patch-clamp experiments
were performed using mitoplasts prepared from isolated mouse brain mitochon-
dria. For mitochondrial isolation, brain tissue was homogenised in 3 ml of isolation
buffer containing 70 mM sucrose, 230 mM mannitol, 2 mM EGTA, 5 mM Hepes-
KOH (pH 7.4), and centrifuged at 800×g for 15 min. Supernatant was centrifuged
at 10 000×g for 15 min. Pellet containing isolated mitochondria was resuspended in
buffer containing 70 mM sucrose, 230 mM mannitol, and 5 mM Hepes-KOH (pH
7.4). Mitoplasts were prepared by following methods: (1) passive swelling in buffer
conation 150 mM KCl, 5 mM Hepes-KOH (pH 7.4), yielding mitoplasts without
PTP; (2) Ca2+ induced swelling in buffer containing 1 mM CaCl2, 1 mM KH2PO4,
150 mM KCl, 5 mM Hepes-KOH, pH 7.4 in the presence of 5 mM succinate and 1
µM rotenone, yielding mitoplasts containing PTP. Patch clamp recordings were
done using borosilicate pipettes (20 MΩ) in symmetrical solution containing 150
mM KCl, 5 mM Hepes-KOH (pH 7.4) using eONE amplifier and acquisition
software. Data were analysed using Clampfit software (Molecular Devices).
Isolation of mitochondria. Mitochondria were isolated from the brain of
Sprague–Dawley rats (200–250 g) where the animal execution was performed
according to the protocol approved by the Animal Care Committee of Dalhousie
University. Brain was homogenised with a Potter–Elvehjem homogenizer in the
mitochondrial isolation buffer (300 mM sucrose, 2 mM EDTA, 5 mM Tris–HCl,
and 0.5 mg/ml bovine serum albumin, pH 7.4). Nuclei and unbroken cells were
spun at 600×g for 10 min, supernatant was collected and spun at 6000×g for 20
min. The resulting pellet was re-suspended in 30 ml of the isolation buffer without
EDTA and BSA and spun at 7500×g for 20 min. The resulting pellet (mitochon-
dria) was re-suspended in 0.5 ml of the isolation buffer without EDTA and BSA
and put on the ice-bath.
Mitochondrial swelling assay. PTP was induced by the addition of small portions
of calcium to energised mitochondria. PTP opening was measured by classical
method of mitochondrial swelling55, which was detected by an in-house-modified
Quantamaster-4 Spectrofluorimeter (PTI, Birmingham, NJ) at 540 nm wavelength.
Experiments were performed at room temperature with continuous mixing.
Complete mitochondrial swelling in some experiments was achieved by the addi-
tion of 5 μM of alamethicin (ala). Mitochondria were added in the final con-
centration 0.5 mg/ml, evaluated in terms of protein concentration, in recording
buffer (Tris–HCl 5 mM; Sucrose 70 mM; Manitol 210 mM; glutamate 5 mM;
malate 1 mM; KH2PO4 0.2 mM, pH= 7.4).
Live cell imaging. For TMRM experiments, cells were incubated with 25 nM
TMRM in a HEPES-buffered imaging solution (Invitrogen) for 40 min at room
temperature. Measurements were obtained by using a Zeiss 710 VIS CLSM
equipped with a META detection system and a 40× oil-immersion objective while
keeping 25 nM TMRM in the imaging solution. TMRM was excited using the 560
nm laser line and fluorescence was measured >580 nm. Z-stack images were
obtained by confocal microscopy and the basal ΔΨm was measured using Zen
software (Zeiss). Assessments of the mitochondrial membrane potential main-
tenance through application of oligomycin, rotenone, and the uncoupler FCCP
were performed through recordings from a single focal plane. TMRM was used in
the redistribution mode to assess the ΔΨm, meaning that a reduction in TMRM
fluorescence represents mitochondrial depolarisation.
Alternatively, cells were loaded with Rh123 (2 μM; Invitrogen) for 15 min and
washed with HBSS prior to the experiment. These loading conditions are nontoxic
and provide ΔΨm measurements through the dequench mode of mitochondrial
fluorescence where an increase in the cytosolic Rh123 fluorescence (measured from
whole cells) redistributed from the mitochondria, reflects mitochondrial
depolarisation. Excitation light was provided by a xenon arc lamp with the beam
passing sequentially through 10 nm band-pass filters centred 490 nm housed in
computer-controlled filter wheel (Cairn Research, UK). Emitted fluorescence light
was reflected through a 515 nm long-pass filter to a cooled CCD camera
(Hamamatsu, Orca ER) and digitised to 12 bit resolution (Digital Pixel Ltd., UK).
Imaging data were collected and analysed using Andor iQ software (Belfast, UK).
The signals were normalised between resting level (set to 0%) and a maximal signal
generated in response to the uncoupler FCCP (1 μM; set to 100%). In some
experiments, 10 µM cyclosporin H was used to block multidrug-resistant pump. No
difference in results ± cyclosporine H has been observed in these cell models.
NADH autofluorescence was measured using an epifluorescence inverted
microscope equipped with a 40× oil-fluorite objective. Excitation at a wavelength of
360 nm was provided by a xenon arc lamp, with the beam passing through a
monochromator (Cairn Research). Emitted light was reflected through a 455 nm
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long-pass filter to a cooled CCD camera (Retiga; QImaging) and digitised to 12 bit
resolution. Imaging data were collected and analysed using software from Andor.
Superoxide production was measured by using dihydroethidium (HEt; 2 μM,
Invitrogen) and HBSS. Fluorescent images were acquired using an epifluorescence
inverted microscope equipped with a 20× fluorite objective (frame interval of 10 s).
The ratio of oxidised and reduced forms of the dye was measured as follows:
excitation was set to 530 nm and emission was recorded above 560 nm to allow
quantification of the oxidised form (ethidium), whereas excitation at 380 nm and
emission from 405 to 470 was used to record the reduced form (hydroethidium).
Data were analysed using software from Andor IQ (Belfast, UK).
Lipid peroxidation was measured using confocal microscopy (Zeiss 710 LSM
with an integrated META detection system). The rate of lipid peroxidation was
measured using C11-BODIPY 581/591 (2 μM; Molecular Probes) which was
excited by the 488 and 543 nm laser line and fluorescence measured using a band-
pass filter from 505 to 550 nm and 560 nm long-pass filter (40× oil-objective).
Illumination intensity was kept to a minimum (0.1–0.2% of laser output) to prevent
phototoxicity and the pinhole was set to give an optical slice of ∼2 μm. Addition of
a bright-field image allowed separation between neurons and glia that are visibly
different and are situated on different focal planes.
ICC and PLA. Cells were fixed in 4% paraformaldehyde and permeabilized with
0.2% Triton-100. 5% BSA was used as to block non-specific binding before cells
were incubated with primary antibodies overnight at 4 °C (1:500 R&D Systems
TuJ1 antibody MAB1195; 1:500 BD α-synuclein antibody 610787; 1:100 Abcam
fibrillar synuclein antibody ab209538 and 1:100 ATP synthase subunit-α antibody
ab14748; BD MAP2 Alexa488 560399; 1:100 Abcam MTCO1 ab14705; 1:200
Abcam Histone H3 ab1220; 1:100 Abcam TOMM20 Alexa488 ab205486). For ICC,
cells were probed with 1:500 Alexa-Fluor 488 (Thermo-Fisher) and 1:500 Alexa-
Fluor 594 (Thermo-Fisher) for 1 h at RT. The PLA was carried out using the
Duolink in situ red kit (mouse/rabbit; Sigma; DUO92101) according to the man-
ufacturer’s instructions. The mounting media contained DAPI to allow for nuclear
staining.
Redox proteomics. For redox proteomics, rat brain mitochondria were isolated as
described above. The mitochondrial sample was divided and treated with either
buffer, monomers or oligomers for 15 min. Mitochondrial protein samples were
either directly separated on a SDS-PAGE using LDS non-reducing sample buffer
(Invitrogen 84788) or a co-IP was performed to pull-down ATP synthase
(ab109715) and the eluent was separated on a SDS-PAGE using LDS non-reducing
sample buffer. The whole sample lines were divided into eight equal parts, excised
and destained overnight. Digestion of proteins was carried out similarly as
described elsewhere56. Samples were washed for 2 h with 5% acetic acid/methanol
(50/50, v/v), followed by dehydration with neat acetonitrile in a vacuum centrifuge
(Eppendorf, Hamburg, Germany) for 5 min. Protein samples were then, reduced
with 10 mM dithiothreitol in 100 mM ammonium bicarbonate, alkylated with 100
mM iodoacetamide in 100 mM ammonium bicarbonate, and digested overnight at
37 °C using 0.6 μg of trypsin gold (Promega) in 50 mM ammonium bicarbonate.
Peptides were extracted with 45% water/50% acetonitrile/5% FA and the volume
was reduced to 20 µl using the vacuum centrifuge57.
The liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis
was performed using shotgun separation of peptide mixtures on a 25 cm reversed-
phase C18 column (75 µm, 2 µm Acclaim RSLC C18, Thermo Scientific, Waltham,
USA) by Easy n-LC II (Thermo Scientific, Waltham, USA) coupled to an Orbitrap
Fusion tribrid mass spectrometer (Thermo Scientific, Waltham, USA). The elution
was carried out over 108 min step gradient at a constant flow rate of 300 nL/min.
Elution started with 5% acetonitrile (with 0.1% FA), ramping to 37% acetonitrile
(with 0.1% FA) from 5 to 95 min, then ramping to 80% acetonitrile (with 0.1% FA)
at 99 min, hold at 80% acetonitrile (with 0.1% FA) for 2 min and back to 5%
acetonitrile (with 0.1% FA) at 108 min.
The Orbitrap Fusion Tribrid analysis was set to data-dependent acquisition
using FTMS master scan preview mode, mass range 400–1600 m/z at 120 000
resolution, for triggering MS/MS events. FTMS data were recorded with a max
injection time of 100 ms, automated gain control (AGC) at 200 000, positive ion
lock mass of 445.12003 m/z and orbitrap as a detector. Monoisotopic precursor
selection filter and dynamic exclusion with 30 s duration was used. Tandem MS
was performed in top-speed mode (3 s cycle time) by quadrupole isolation using
HCD fragmentation with the 30% of normalised collision energy, max injection
time of 70 ms, AGC at 10 000 and ion trap as detector.
MS data were analysed with SEQUEST HT search engine in Proteome
Discoverer 1.4 (Thermo Scientific, San Jose, CA, USA) against Uniprot Rattus
norvegicus database (downloaded on 12th October 2017). The search parameters
for HCD-ITMS fragment ions used were as follows: 10 ppm precursor mass
tolerances, 0.6 Da fragment mass tolerance, maximum of two missed cleavages
were allowed for tryptic peptides, min/max precursor mass was set to 350/5000 Da,
the peptide false discovery rate calculated by a target–decoy approach was set to
0.01. Additionally, 12 different types of variable modifications of peptides were
searched. The modifications included were as follows: carbamidomethylation of
cysteine, C-terminal oxidation and terminal independent carbonylation
(+13.97926 Da), mono-oxidation (+15.99491 Da), di-oxidation (+31.98982 Da),
tri-oxidation (+47.985 Da), oxidation of His to Asn (−23.0159 Da) or Asp
(−22.032 Da) and oxidation of lysine to aminoadipic acid (+14.9632 Da)
(Supplementary Table 1). Peptides with medium (p < 0.05) and high confidence (p
< 0.01) were used for initial filtering of data for comparative redox proteomics
analysis.
To quantify the ratio of peptides with oxidised methionine vs non-oxidised
([Met(O)]/[Met]) according to Suzuki et al.57, peptide ion intensities were
extracted from the MS/MS files of representative samples using Precursor Ions
Area Detector node in Proteome Discoverer. The degree of oxidation was measured
by comparing the integrated peak areas of the [Met(O)]/[Met] peptides. The mass
spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE58 partner repository with the dataset identifier
PXD009416.
Cell toxicity experiment. Cells were incubated with PI (20 μM) and Hoechst
33342 (4.5 µM; Molecular Probes, Eugene, OR). Viable cells exclude the red
fluorescent PI whereas Hoechst stains chromatin blue in all cells thus allowing dead
cells to be quantified.
Super-resolution. Two colour super-resolution was achieved using DNA
PAINT15. Prior to imaging, the cells were fixed in 4% paraformaldehyde and
permeabilized with 0.2% Triton-100. 10% Goat Serum (Sigma Aldrich) was used to
block non-specific binding before cells were incubated with primary antibodies
overnight at 4 °C (Abcam; 1:100 fibrillar synuclein antibody ab209538; 1:100 ATP
synthase subunit-α antibody ab14748). The primary antibodies were probed using
biotinylated secondary antibodies bound to DNA oligonucleotides via a
biotin–streptavidin sandwich, which were prepared according to Jungmann et al.
[15]. Briefly, 5 µl of biotinylated DNA docking strand (100 µM) (ATDBio LTD.,
Southampton, UK), 5 µl streptavidin (5 mg/ml) (Sigma-Aldrich, S4762), and 90 µl
PBS were incubated at RT whilst gently shaking for 30 min. 1 µl of biotinylated
secondary antibody (1 mg/ml) was then added to the solution and incubated for a
further 30 min. Filter columns (Amincon, 100 kDa) were used to purify the pre-
assembled conjugates from the unreacted streptavidin–DNA. The sequences of the
DNA strands attached to the antibodies (docking strands) and to the fluorophores
(imaging strands) are given below. DNA-PAINT utilises a fluorophore labelled
imaging DNA strand that transiently binds to a complementary docking strand
conjugated to the secondary antibody that binds the primary antibody, allowing it
to be imaged at an equivalent high precision >20 nm. The cells were incubated with
both secondary antibodies at a concentration of 10 µg/ml for 1 h. The imaging
strand was added to the cells at an imaging concentration of 1 nM. Controls
utilising untreated cells, primary antibodies alone and secondary antibodies alone
were performed in parallel.
Docking strand for secondary antibody to fibrillar antibody: Biotin-
TTATACATCTA
Imaging strand for secondary antibody to fibrillar antibody: CTAGATGTAT-
ATTO655
Docking strand for secondary antibody to ATP Synthase antibody:
Biotin–TTATCTACATA
Imaging strand for secondary antibody to ATP Synthase antibody:
TATGTAGATC-CY3B
For the TOMM20 and complex-1 imaging (Supplementary Fig. 3), the same
sequences were used, only the biotin was exchanged for a thiol and directly
conjugated to the secondary antibody using a maleimide-PEG2-succinimidyl
ester59. Equivalent imaging with ATP5A is also shown in Supplementary Fig. 3.
The association quotients, Q, were calculated for each of these images generated.
Images were recorded on a custom-built instrument consisting of an Nikon TiE
inverted microscope with an infinity-corrected oil-immersion objective using TIRF
illumination (Olympus UPlanApo TIRF, ×60, 1.49 NA) and detected on an
EMCCD camera (Photometrics Evolve, EVO-512-M-FW- 16-AC-110). Images
were acquired at 50 ms per frame operating in frame transfer mode with an election
multiplication gain of 250 fold. We used a dichroic mirror (Semrock, Di01-R405/
488/561/635), and emission filters for Cy3B (Semrock, LP02-568RS-25 and FF01-
587/35-25) and Alexa-Fluor 647 (Semrock BLP01-635R-25). Images were acquired
through excitation at 561 and 641 nm (∼4 kW/cm2) for 8000 frames. The
diffraction limited images were generated by taking the standard deviation of the
intensity over the frames of the image stack.
Super-resolution images were analysed using the GDSC Single Molecule Light
Microscopy plugin Peak Fit in ImageJ (Alex Herbert, University of Sussex, UK) by
fitting to a 2D Gaussian function using the Least Squared Errors method. A noise
threshold of 20 was used, with a precision cut-off of 50 nm. To remove spurious
localisations, cluster analysis of the super-resolution images was performed using
DBSCAN compiled in the python60. A distance threshold of 1 pixel (135 nm) was
used, and clusters were defined as those with more than 20 localisations; all other
localisations were discarded. The resolution was determined by plotting a Fourier
ring correlation curve (GDSC SMLM package)61 for each image and determining
the spatial frequency at which the curve drops below 1/762.
To determine the percentage co-localisation, α-synuclein localisations were
defined as being coincident with the mitochondrial marker if their positions plus
their fitting precisions were within mitochondrial marker localisations plus their
fitting precisions. The number of chance coincident events was estimated by
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performing the same analysis with simulated ATP synthase images having the same
densities of localisations.
The association quotient (Q) was calculated according to the following
equation63:
Q ¼ C  E
A E ð1Þ
where Q is the association quotient, C is the number of coincident events in
both filament and mitochondrial images, E is the estimated number of chance co-
localisations, and A is the total filament localisations.
Statistical analysis. Origin 9 software was employed for the statistical analysis and
exponential curve fitting. Biological replicates are termed ‘N’; number of cells
analysed is termed ‘n’. Data was assessed for normality using the Shapiro–Wilk test.
Experimental data are shown as means ± SEM, with superimposed scatter points to
demonstrate variance within datasets. Statistical analysis was performed using
unpaired two-tailed Student’s t test to analyse differences between two groups, or a
one-way ANOVA with a Bonferroni correction to analyse differences among three
or more groups. Differences were considered to be significantly different if p < 0.05.
Data availability. Data supporting the findings of this manuscript are available
from the corresponding authors upon reasonable request. Proteomic data is
available via ProteomeXchange with identifier PXD009416.
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